2FIRSTS INTERVIEW WITH SPANISH HEALTH MINISTRY: No Impending Restrictions for Vape Flavors

Regulations by 2FIRSTS
Jan.11.2024
2FIRSTS INTERVIEW WITH SPANISH HEALTH MINISTRY: No Impending Restrictions for Vape Flavors
The Spanish Ministry of Health has stated that it plans to approve the previously unpassed "Comprehensive Anti-Tobacco Plan" in the first half of 2024. Subsequently, the key milestones for implementation will be determined. Additionally, the current flavor restrictions are only applicable to HTPs, with no imminent plans to extend them to e-cigarettes.

Entering 2024, Spain's newly appointed Minister of Health, Mónica García, will face a series of challenges in the field of tobacco control. To understand the latest policy developments in the country, 2FIRSTS conducted an exclusive interview with her. The ministry expressed its plans to approve the Comprehensive Tobacco Control Plan, which had not been passed by the previous government, in the first half of 2024. Subsequently, key timelines for its implementation will be determined. Furthermore, the restrictions on flavors currently only apply to heated tobacco products, with no imminent plans to expand into the e-cigarette domain.

 

The following is a transcript of the exclusive interview:

 

Q: According to our sources, the 2021-2025 Comprehensive Tobacco Control Plan proposed by Spain's former Minister of Health is set to be a focal point next year. Can the Ministry of Health provide an explanation of this government's stance on the plan, as well as the personal contributions made by the current Minister of Health, Mónica García, in refining its details?

 

A: The comprehensive smoking prevention and control plan for 2022-2025 has been extensively researched and coordinated through close collaboration among local governments, scientific societies, and other stakeholders. It is now ready to be submitted for final evaluation and approval by the inter-regional committee. The plan encompasses interdisciplinary measures and actions in various areas, primarily focusing on regulations, healthcare, environmental protection, and coordination. Within these four aspects, a series of specific goals have been formulated, including the prevention of smoking initiation, promoting smoking cessation, reducing environmental exposure and ecological footprints, and facilitating research and monitoring.

 

Q: Has the Ministry of Health implemented a clear implementation plan regarding this plan so far?

 

A: The department's plan is to approve the plan within the first half of 2024, and subsequently determine the key milestones for implementation.

 

Q: It is worth noting that there has been a two-year gap between the proposal and implementation of this plan. Since the passing of the Act 579/2017 in 2017, there has been a legal void for a period of five years. How would you explain this gap in legislation and enforcement?

 

A: In the previous government, the plan was not proposed or approved, so there was no two-year delay between proposal and execution. Regarding the absence of the new law, it is worth mentioning that reform requires the proposal and approval of the plan as a first step. Finally, it is worth mentioning that there has indeed been a change in the regulatory field. Currently, the implementation of the relevant directive on heated tobacco is imminent. Currently, the process has reached its final stage and has obtained the endorsement of the State Council, with only the approval of the State Council remaining as the final step.

 

Q: What is the minister's perspective on e-cigarettes? In the foreseeable future, are e-cigarettes considered as a means to reduce tobacco-related harm or as an alternative tobacco production method in Spain?

 

A: Currently, scientific evidence has yet to confirm the supposed reduction in harm of e-cigarettes. In Spain, all scientific societies and local governments unanimously oppose this viewpoint. Therefore, the agreement reached by the Health Public Committee of the National Health System's Interregional Committee explicitly states: "Therefore, the Health Public Committee of the National Health System's Interregional Committee, with the objective of promoting public health and preventing smoking-related diseases, warns that the use of traditional tobacco products, so-called 'heated tobacco products' (non-combustible), and 'nicotine-releasing devices' (e-cigarettes) all carry health risks. It is therefore advised not to consume any of these products.

 

Q: According to Law No. 579 of 2017, Spain has prohibited the use of menthol and flavored cigarettes. In the future, will this flavor restriction also apply to e-cigarettes?

 

A: Currently, the Royal Decree 579/2017 of 2017 is undergoing review. As mentioned earlier, its scope is limited to heated tobacco products and therefore does not affect e-cigarettes.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
Less than a week after JUUL2 received U.S. FDA marketing authorization on August 28, 2026, JUUL Labs was sued for patent infringement in federal court in Delaware. AJ Marketing LLC filed the complaint on September 3, alleging that both JUUL 1 and JUUL2 infringe U.S. Patent No. 8,851,068 B2. The patent covers aspects of programmable electronic vaporization devices, including controls over dose delivery, usage frequency and operating parameters. The plaintiff is seeking reasonable royalties and ongoing royalties tied to the remaining life of the patent. JUUL has not yet publicly responded to the case.
Sep.10
Product | JNR Launches Crown Shisha 100K for International Wholesale, Pairing 58ml Capacity With Triple-Mesh DTL Design
Product | JNR Launches Crown Shisha 100K for International Wholesale, Pairing 58ml Capacity With Triple-Mesh DTL Design
JNR released the Crown Shisha 100K on August 14, 2026, positioning the ultra-high-capacity disposable around a direct-to-lung (DTL) e-shisha experience. The device combines a 58ml e-liquid capacity, triple 1.0Ω mesh coils and a 1,300mAh rechargeable battery, with JNR claiming up to 100,000 puffs. Adjustable airflow, battery and e-liquid status displays, a leather-style exterior and a shisha-inspired sound effect further differentiate the product. JNR is currently promoting the device through international wholesale and distribution channels, while a specific first retail market has not been disclosed.
Aug.31
China’s Zhengzhou Tobacco Research Institute develops end-to-end heated tobacco analysis to trace aerosol compound origins
China’s Zhengzhou Tobacco Research Institute develops end-to-end heated tobacco analysis to trace aerosol compound origins
The Zhengzhou Tobacco Research Institute of China National Tobacco Corporation has filed a patent application for an end-to-end method to analyze the migration and transformation of chemical compounds in heated tobacco products. Using GC-Orbitrap/MS non-targeted analysis, the method compares tobacco substrate and aerosol samples to distinguish compounds transferred directly from the substrate from those newly formed during heating, while also calculating transfer rates. In an example involving nine heated tobacco products, the patent identified 17 newly formed thermal decomposition compounds and 38 transferred compounds.
Aug.13
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Philip Morris International (PMI) has launched ZYN Melts in the UK, introducing a fully dissolvable oral nicotine tablet format alongside the brand's existing nicotine pouches. The range includes Cool Mint and Peppermint, each offered at 1mg and 2mg of nicotine per tablet, creating four SKUs. Each can contains 20 tablets and is priced at £6.50 in the UK. Unlike ZYN nicotine pouches, Melts are placed between the upper lip and gum and dissolve completely during use.
News
Sep.29 by 2Firsts Perspectives
Yinghe-Controlled Vape Maker SKE Ordered to Post £569,039 Security as It Pursues Crystal Bar Design Infringement Case in UK
Yinghe-Controlled Vape Maker SKE Ordered to Post £569,039 Security as It Pursues Crystal Bar Design Infringement Case in UK
The UK High Court has ordered Chinese vape manufacturer Shenzhen SKE Technology to provide £569,039 ($776,000) in security for costs in its design infringement proceedings against Vapepen London and other defendants over its Crystal Bar vape product. The court did not accept the defendants’ main argument that recovering costs from a China-based company would face significant enforcement obstacles, but found that SKE had not sufficiently disclosed its own financial position. The order is procedural and does not determine the underlying infringement claims.
News
Aug.21